Revelation Pharma, a US-based national network of 503A and 503B compounding pharmacies, announced on Thursday its acquisition of Acacia Apothecary & Wellness, a compounding pharmacy serving Tucson, Arizona.
According to Revelation, this acquisition expands its footprint and strengthens its expertise in hormone therapy, women's health, and personalised medicine.
Founded in 2014 by Justin and Heather Brock, Acacia Apothecary has two Tucson locations and customers across both human and veterinary medicine.
As part of the acquisition, Justin Brock, PharmD, will join Revelation Pharma as an operational consultant. Brock was recently named a Fellow of the Alliance for Pharmacy Compounding (APC), and is an active advocate for advancing compounding standards and access.
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign